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Background: Hypertension is one of the largest causes of preventable morbidity and mortality worldwide. There
are few population-based studies on hypertension epidemiology to guide public health strategies in sub-Saharan
Africa. Using a community-based strategy that integrated screening for HIV and non-communicable diseases, we
determined the prevalence, awareness, treatment rates, and sociodemographic factors associated with hypertension
in rural Uganda.
Methods: A household census was performed to enumerate the population in Kakyerere parish in Mbarara district,
Uganda. A multi-disease community-based screening campaign for hypertension, diabetes, and HIV was then
conducted. During the campaign, all adults received a blood pressure (BP) measurement and completed a survey
examining sociodemographic factors. Hypertension was defined as elevated BP (≥140/≥90 mmHg) on the lowest
of three BP measurements or current use of antihypertensives. Prevalence was calculated and standardized to age
distribution. Sociodemographic factors associated with hypertension were evaluated using a log-link Poisson
regression model with robust standard errors.
Results: Community participation in the screening campaign was 65%, including 1245 women and 1007 men. The
prevalence of hypertension was 14.6%; awareness of diagnosis (38.1%) and current receipt of treatment (20.6%)
were both low. Age-standardized to the WHO world standard population, hypertension prevalence was 19.8%,
which is comparable to 21.6% in the US and 18.4% in the UK. Sociodemographic factors associated with
hypertension included increasing age, male gender, overweight, obesity, diabetes, alcohol consumption, and family
history. Prevalence of modifiable factors was high: 28.3% women were overweight/obese and 24.1% men
consumed ≥10 alcoholic drinks per month.
Conclusions: We found a substantial burden of hypertension in rural Uganda. Awareness and treatment of
hypertension is low in this region. Enhanced community-based education and prevention efforts tailored to
addressing modifiable factors are needed.
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Increasing urbanization has fueled social and economic
changes in sub-Saharan Africa, which have contributed
to a surge in non-communicable disease (NCD), in-
cluding hypertension [1,2]. High blood pressure is the
leading risk factor for mortality worldwide and approxi-
mately 80% of all cardiovascular deaths occur in low-
and middle-income countries [3-5]. It is predicted that
more than 125 million adults in sub-Saharan Africa
alone will have hypertension by 2025 [6,7]. Given the
long-term decreased productivity associated with hyper-
tension, identifying and treating a large proportion of
patients has the potential to generate tremendous social
and economic benefits in this region [8-13].
Despite the recognition of hypertension as a major
threat to public health in sub-Saharan Africa, epidemio-
logic research to guide public health approaches to pre-
vent and treat hypertension is limited in scope, sample
size, methodology, and generalizability of conclusions
[7,8,12,14-16]. Robust population-based data using sound
statistics are still needed to confirm prior estimates and
inform policy debates. Further, strategies that allow hyper-
tension screening on a population level need to be deve-
loped in these resource-limited settings.
Novel community- and home-based testing programs
are being deployed as a means to diagnose and treat
HIV in sub-Saharan Africa [17,18]. These programs ad-
dress barriers such as high cost of accessing clinic-based
testing, inadequate primary care services and lack of
awareness about testing. Leveraging this HIV targeted
infrastructure can improve services for NCDs, especially
in the context of a fragile health care delivery system
[12,19-22]. Building these strategic partnerships can also
be used to study the epidemiology of NCDs.
The Sustainable East Africa Research in Community
Health (SEARCH) collaboration has pioneered multi-
disease prevention and treatment services that integrate
HIV and NCD services through community-based scree-
ning campaigns. In a prior pilot campaign conducted
in May 2011 in a rural community of southwestern
Uganda, we found a significant burden of untreated
hypertension [23]. In the present study, we sought to
determine the prevalence, awareness, treatment rates
and sociodemographic factors associated with hyper-
tension in this community using an approach that in-
tegrates HIV and NCD testing.Methods
Study setting
The study was conducted in Kakyerere parish within
Mbarara district in southwestern Uganda. A parish is
an administrative unit in Uganda that consists of
multiple villages. Kakyerere parish includes 9 villagescomprising approximately 6,500 persons with 50% of
the population ≥18 years [23].
Community census
A community-wide household level census was per-
formed in Kakyerere parish. Trained staff, with the help
of local leaders, identified and attempted to visit all
households within the boundary of the parish. When a
visit was made, the head of the household provided
informed consent to collect demographic information
about all household members. A unique household-
identifier was given to each household, which was used to
accurately identify participants at the community health
campaign. The census allowed ascertainment of com-
munity participation in the campaign, understanding of
basic sociodemographics of non-participants, and calcula-
tion of age-standardized measures for the whole parish
population.
Community health campaign
Community health campaigns (CHC) are large public
health initiatives that provide rapid diagnostic services
for multiple diseases in rural areas. Prior to the cam-
paign, local leaders designed and executed community
mobilization measures including radio announcements
and posters in order to maximize participation at the
CHC. Local health personnel staffed each campaign and
provided services for adults and children at community
sites such as schools and churches. The CHC occurred
over five days and each adult participant received point-
of care screening for HIV, hypertension, and diabetes.
Those screening positive for any disease were given a
follow-up appointment at a local health facility for fur-
ther management. Children were offered HIV testing,
rapid diagnosis and treatment for malaria, and deworm-
ing. Each person who joined in the CHC participated on
one campaign day for 2–3 hours. The campaign is “high
throughput” because it provides rapid services for a large
population (approximately 1,000 persons/day). Detailed
procedures regarding the implementation of a CHC in
Kakyerere parish have been recently described by our
group [23].
Blood pressure measurement
All adult CHC participants received blood pressure (BP)
screening and completed an epidemiologic survey at the
CHC. Inclusion criteria were age ≥18 years and resi-
dence in Kakyerere parish. Hypertension was defined as
systolic BP ≥140 mmHg or diastolic BP ≥90 mmHg per
the World Health Organization (WHO)/International So-
ciety of Hypertension (ISH) guidelines [24]. Hypertension
was further classified as Stage 1 (140-159/90-99 mmHg)
or Stage 2 (≥160/≥100 mmHg) based on the Seventh
report of the Joint National Committee on prevention,
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sure (JNC7) guidelines [25].
Trained staff conducted BP measurements using an
electronic, automated sphygmomanometer (Honsun
LD7A), with small (<21 cm), normal (22–32 cm), and
large (>33 cm) cuff sizes. Subjects were seated in a
chair and rested for approximately one minute before
BP was measured. Following initial BP measurement,
participants who met criteria for hypertension during
this screen underwent two repeat measurements one
minute apart. The lowest of three measurements was
used to establish a diagnosis of hypertension.
Height was measured to the nearest 0.1 cm after re-
moval of shoes. Weight was measured to the nearest
kilogram after removal of shoes and heavy clothing.
Body mass index (BMI) was calculated to determine pro-
portion of overweight (25.0-29.9 kg/m2) and obese
(≥30 kg/m2) participants. In addition, point-of-care ran-
dom plasma glucose (Optium Xeed - Abbot) and HIV
rapid tests (Determine HIV-1/HIV-2 (Abbot); HIV-1/2
Stat-Pak assay; and Uni-Gold HIV Rapid test) were also
performed. Trained staff conducted a survey to deter-
mine sociodemographic factors and treatment history
for hypertension.
Hypertension treatment referral
Hypertensive adults identified at the CHC were given a
referral appointment to a local government health fa-
cility, where they received treatment per the Ugandan
Ministry of Health guidelines [26]. Government health
facilities in Uganda are required to offer free services to
all persons, including supply of antihypertensive medica-
tions. In the event of antihypertensive drug shortages at
government facilities, patients are occasionally referred
to private retail pharmacies to obtain antihypertensive
medications. In a previous report, the monthly cost of
purchasing antihypertensives has been estimated at 1.1
Euros (1.4 US Dollars) in a similar region of sub-Saharan
Africa [27].
Data analysis
Survey data were collected via a computerized interview
programmed onto data tablets. Stata v.12 (Stata Corpor-
ation) was used for all analyses.
Hypertension was defined as systolic BP ≥140 mmHg
or diastolic BP ≥90 mmHg on lowest of three BP mea-
sures or current use of antihypertensives. Age-standard-
ized prevalence of hypertension was calculated using the
Kakyerere parish community-wide census population,
2000 US census population [28], and WHO world stan-
dard population [29]. Awareness of a diagnosis of
hypertension was defined by self-report among those
determined to be hypertensive. BP control was defined
as having BP below hypertension threshold (systolicBP < 140 and diastolic BP < 90 mmHg) if currently taking
antihypertensives.
We conducted a sensitivity analysis on our prevalence
estimate to account for transient changes in BP levels.
The upper estimate was calculated by including those
with self-reported hypertension but normal BP on
screening. The lower estimate was calculated by using a
stricter definition of hypertension, systolic BP ≥160 or
diastolic BP ≥95 mm Hg.
Sociodemographic factors that may be associated with
hypertension prevalence were analyzed. Specifically, we
evaluated age, gender, BMI, level of education, occupation,
smoking status, alcohol consumption, family history, and
random plasma glucose. Due to well-established links be-
tween HIV and cardiovascular complications [30], we also
assessed HIV status.
Associations between sociodemographic factors and
hypertension were investigated using a multivariable log-
link Poisson model with robust standard errors to esti-
mate adjusted prevalence ratios. All sociodemographic
factors were included a priori in the multivariable re-
gression model. Analyses were stratified by gender.
Ethics
The study was reviewed and approved by the Makerere
University School of Medicine Research and Ethics
Committee, the Ugandan National Council on Science
and Technology, and the UCSF Committee on Human
Research.
Results
Characteristics of study participants
2,282 adults attended the CHC and 2,252 (99%) were
screened for hypertension and answered epidemiologic
survey at the CHC. These persons represented 65% of
the 3,485 adults (1,861 women and 1,624 men) enumer-
ated in the Kakyerere parish community census. Partici-
pation in the CHC was higher among women (66.9%)
than men (62.0%) (P = 0.002) (Table 1). Participation was
lowest among 18–29 year olds for both women (56.6%,
P < 0.0001) and men (58.4%, P = 0.005).
Demographic and clinical characteristics are listed in
Table 2.
Prevalence, awareness, treatment and control of
hypertension
The overall unadjusted prevalence of hypertension in
this community was 15.7%. Hypertension prevalence
was 16.1% among men and 15.4% in women (P = 0.67)
(Table 2). Per JNC7 classification [25], 9.4% partici-
pants had Stage 1 hypertension while 5.0% had Stage
2 hypertension.
A large fraction of patients were not aware of being
hypertensive and received a new diagnosis at the CHC.
Table 1 Number of community members screened for
hypertension at the community health campaign (CHC) in
Kakyerere parish, in categories of age and gender
Women:
Age Persons screened Community participation (%)
18–29 478 56.6
30–44 415 75.4
45–59 194 75.8
≥60 158 75.2
Total 1245 66.9
Men:
Age Persons screened Community participation (%)
18–29 448 58.4
30–44 315 62.4
45–59 151 68.9
≥60 93 69.4
Total 1007 62.0
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tensive women were aware of their diagnosis compared
to only 23.5% men (P < 0.0001). Self reported use of anti-
hypertensives was also significantly more common among
women (28.6%) compared to men (11.1%) (P < 0.0001).
Among those using antihypertensive medication, a similar
proportion of women (40.0%) and men (38.9%) achieved
BP control (normotensive on reported therapy) (P = 0.93).Age-standardized prevalence
Using the Kakyerere parish household census population
age distribution, the age-standardized prevalence for the
entire community was 14.6%, (95% confidence interval
(CI) 13.3-15.9; with women at 13.4%, and men at 16.0%).
Using the 2000 US census population and the WHO
world standard population, the age-standardized preva-
lence was 22.0% (95% CI 20.0-24.0) and 19.8% (95% CI
18.0-21.5), respectively (Table 3).Sociodemographic factors associated with hypertension
Among women, significant associations with hyperten-
sion in the adjusted regression model included age, BMI,
and diabetes (random plasma glucose ≥11.1 mmol/L)
(Table 4). Age ≥60 years was associated with a marked
elevation in hypertension prevalence compared to age
18–29 years (PR = 12.30; 95% CI 6.59-22.10). Similarly,
the prevalence of hypertension increased with BMI:
overweight and obese women were more likely to be
hypertensive (PR = 1.75; 95% CI 1.28-2.40, and PR = 2.72;
95% CI 1.94-3.83, respectively). Diabetes was also asso-
ciated with substantially increased likelihood of being
hypertensive (PR = 2.44; 95% CI 1.32-4.51).Among men, sociodemographic predictors of hyper-
tension included age, BMI, alcohol use, HIV status, and
family history. Increasing age was associated with an in-
crease in the prevalence of hypertension: older men
(≥60 years) were six times as likely to have hypertension
compared to younger men (18–29 years), PR = 6.00 (95%
CI 3.10-11.58). Increase in BMI was also associated with
a greater hypertension prevalence: PR = 2.12 (95% CI
1.45-3.11) for overweight men and PR = 1.64 (95% CI
0.84-3.22) for obese men. Men consuming ≥10 alcoholic
drinks per month had 60% higher prevalence of hyper-
tension compared to non-drinkers, PR = 1.60 (95% CI
1.13-2.26). HIV infected men were less likely to be
hypertensive, PR = 0.39 (95% CI 0.17-0.87). Men with a
family history of hypertension in first degree relatives
were 1.5 times as likely to have hypertension than those
without a family history, PR = 1.51 (95% CI 1.12-2.04).
In a separate multivariable model including gender,
men were 1.3 times more likely to have hypertension
than women after adjustment for all other variables, PR
= 1.34 (95% CI 1.05-1.69) (data not shown).
Sensitivity analysis
Estimated prevalence of hypertension was 19.7% (women
20.8% and men 18.3%) if those with self-reported hy-
pertension were considered. A lower estimate of 6.6%
(women 6.7% and men 6.4%) was obtained by using more
stringent BP measures (SBP ≥160 or DBP ≥ 95 mm Hg).
Discussion
Using a community-based strategy that integrated HIV
and NCD screening, we found a substantial burden of
hypertension (14.6% age-standardized prevalence) ac-
companied by low rates of awareness of the condition.
Among individuals aware of their hypertension, we
found low rates of therapy. Furthermore, we found a
high prevalence of multiple modifiable factors associated
with hypertension. Our study, by leveraging a multi-
disease CHC to study hypertension, demonstrates that
strategic public health investments in HIV and NCDs
can be complementary and efficient in providing diag-
nostic services in Sub-Saharan Africa.
Using this community-based approach we provide
estimates of hypertension prevalence in the range of
those previously reported from Uganda [12,31] and
sub-Saharan Africa [7]. Age-standardized to the WHO
world standard population, hypertension prevalence in
Kakyerere parish was 19.8%, which is comparable to
21.6% in the US and 18.4% in the UK [32]. This find-
ing adds to accumulating evidence that prevalence of
hypertension in sub-Saharan Africa is approaching
that in developed nations [6,32-35]. Further, our data
are especially concerning when considering that rural
areas in Sub-Saharan Africa have a lower prevalence
Table 2 Demographic and clinical characteristics of study participants
Women Men Total
(N = 1245) (N = 1007) (N = 2252)
N (%)
Age (years)
18–29 478 (38.4%) 448 (44.5%) 926 (41.1%)
30–44 415 (33.3%) 315 (31.3%) 730 (32.4%)
45–59 194 (15.6%) 151 (15.0%) 345 (15.3%)
≥ 60 158 (12.7%) 93 (9.2%) 251 (11.2%)
Marital statusa
Single 172 (14.6%) 300 (32.7%) 472 (22.5%)
Married (ever) 1009 (85.4%) 618 (67.3%) 1627 (77.5%)
BMI (kg/m2)b
≤ 25 892 (71.7%) 923 (91.7%) 1815 (80.6%)
25 – 30 243 (19.5%) 68 (6.8%) 311 (13.8%)
≥ 30 110 (8.8%) 15 (1.5%) 125 (5.5%)
Occupation
Unemployed 158 (12.7%) 176 (17.5%) 334 (14.8%)
Manual 1014 (81.4%) 758 (75.3%) 1772 (78.7%)
Sedentary 73 (5.9%) 73 (7.2%) 146 (6.5%)
Education level
No school 310 (24.9%) 94 (9.3%) 404 (17.9%)
Primary 651 (52.3%) 532 (52.8%) 1183 (52.5%)
Secondary 222 (17.8%) 297 (29.5%) 519 (23.1%)
Tertiary and beyond 62 (5.0%) 84 (8.3%) 146 (6.5%)
Acres of land ownedc
None 142 (12.4%) 96 (10.2%) 238 (11.4%)
≤ 1 282 (24.5%) 157 (16.6%) 439 (21.0%)
1–5 484 (42.1%) 370 (39.2%) 854 (40.8%)
≥ 5 242 (21.0%) 322 (34.1%) 564 (26.9%)
Current tobacco use
No 1208 (97.0%) 783 (77.8%) 1991 (88.4%)
Yes 37 (3.0%) 224 (22.2%) 261 (11.6%)
Alcohol use (drinks consumed per month)d
None 986 (79.3%) 527 (52.4%) 1513 (67.3%)
0–10 196 (15.7%) 236 (23.5%) 432 (19.2%)
≥ 10 62 (5.0%) 242 (24.1%) 304 (13.5%)
HIV
Negative 1107 (88.9%) 923 (91.7%) 2030 (90.1%)
Positive 138 (11.1%) 84 (8.3%) 222 (9.9%)
Random plasma glucose (mmol/L)e
0–7 1101 (88.7%) 895 (89.2%) 1996 (88.9%)
7–11 126 (10.2%) 103 (10.3%) 229 (10.2%)
≥ 11.1 14 (1.1%) 5 (0.5%) 19 (0.9%)
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Table 2 Demographic and clinical characteristics of study participants (Continued)
Family historyf
No 962 (79.5%) 798 (81.6%) 1760 (80.4%)
Yes 248 (20.5%) 180 (18.4%) 428 (19.6%)
Blood pressure (BP) (mm Hg)
Systolic Blood Pressure Mean (SD) 122.5 (18.6) 125.5 (16.7) 123.8 (17.9)
Diastolic Blood Pressure Mean (SD) 74.9 (12.1) 74.8 (11.7) 74.9 (11.9)
Hypertension (elevated BP or taking antihypertensives) 192 (15.4%) 162 (16.1%) 354 (15.7%)
BP ≥140/≥90mm Hg 170 (13.7%) 155 (15.4%) 325 (14.4%)
Stage 1 (140–159/90–99) 104 (8.4%) 108 (10.7%) 212 (9.4%)
Stage 2 (≥160/≥100) 66 (5.3%) 47 (4.7%) 113 (5.0%)
Self-reported hypertension 164 (13.2%) 60 (6.0%) 224 (10.0%)
Awareness (if hypertensive, N = 354) 97 (50.5%) 38 (23.5%) 135 (38.1%)
Receiving treatment (if hypertensive, N = 354) 55 (28.6%) 18 (11.1%) 73 (20.6%)
BP controlled (if receiving treatment, N = 73) 22 (40.0%) 7 (38.9%) 29 (39.7%)
aN = 2099, female = 1181, male = 918.
bN = 2251, female = 1245, male = 1006.
cN = 2095, female = 1150, male = 945.
dN = 2249, female = 1244, male = 1005.
eN = 2244, female = 1241, male = 1003.
fN = 2188, female = 1210, male = 978.
Kotwani et al. BMC Public Health 2013, 13:1151 Page 6 of 10
http://www.biomedcentral.com/1471-2458/13/1151of hypertension compared to semi-urban and urban
areas [16,36-39].
Awareness of a hypertension diagnosis (38.1%) was in-
adequate and especially poor among men (23.5%). In a
review, Addo et al. [11] report that hypertension aware-
ness in sub-Saharan Africa was generally below 40%,
consistent with our results. Despite being aware, how-
ever, only one out of five known hypertensives was re-
ceiving treatment. Further, BP control was achieved in
only 39.7% of hypertensive patients on therapy. Addres-
sing these gaps requires health system strengthening.
Community health campaigns can be a key component
of new strategies that build both individual and commu-
nity level awareness of NCDs such as hypertension.
Sociodemographic factor analysis identified groups of
persons most likely to be hypertensive - these persons
can serve as the target for prevention strategies in rural
Uganda. Further, modifiable factors associated with hy-
pertension in this population include overweight, obe-
sity, alcohol consumption, and diabetes—all consistent
with prior reports [9,12,15,31,40]. BMI and hypertensionTable 3 Age-standardized prevalence of hypertension using t
2000 U.S. standard population, and the WHO world standard
Pr
Study participants
(unadjusted)
Kakyerere Parish hou
census populatio
Total 15.7% (14.2–17.2) 14.6% (13.3–15.9
Women 15.4% (13.4–17.4) 13.4% (11.7–15.1
Men 16.1% (13.8–18.4) 16.0% (13.9–18.2had a strong relationship among both women and men,
while a relationship with alcohol consumption (≥10
drinks/month) was found in men only. Three out of ten
women were either overweight or obese compared to
only one out of ten men. 24.1% men consumed ≥10 al-
coholic drinks/month compared to only 5% women.
Our data also emphasize the need for greater diagnosis
and treatment of diabetes, particularly among women.
The small number of men found to have elevated blood
glucose prevented meaningful analysis of the link between
diabetes and hypertension in men. Consistent with other
studies across sub-Saharan Africa [11,12,15,40], hyperten-
sion had a strong relationship with both increasing age
and male gender. Family history was independently related
to hypertension among men but not women. These data
can be utilized to stratify risk and inform hypertension
treatment decisions in rural Uganda.
Interestingly, HIV infected men were less likely to
be hypertensive even after multivariable adjustment,
PR = 0.39 (0.17-0.87). Previously, Barnighausen et al.
reported a 3.0 mm Hg decrease in systolic BP withhe Kakyerere Parish household census population, the
population among adults ≥18 years
evalence (95% CI)
sehold
n
2000 US census
population
WHO world standard
population
) 22.0% (20.0–24.0) 19.8% (18.0–21.5)
) 21.1% (18.5–23.6) 18.7% (16.5–21.0)
) 23.1% (19.9–26.2) 21.0% (18.2–23.8)
Table 4 Risk factors associated with hypertension using a log-link Poisson model with robust standard errors
Women (N = 1245a) Men (N = 1007a)
Proportion with
hypertension (%)
Unadjusted
prevalence ratio
Adjustedb
prevalence ratio
Proportion with
hypertension
Unadjusted
prevalence ratio
Adjustedb
prevalence ratio
PR (95% CI) PR (95% CI) (%) PR (95% CI) PR (95% CI)
Age (years) P < 0.0001 P < 0.0001 P < 0.0001 P < 0.0001
18–29 16/478 = 3.4% 1 1 29/326 = 6.5% 1 1
30–44 58/415 = 14.0% 4.18 (2.44–7.15) 3.93 (2.15–7.18) 50/315 = 15.9% 2.45 (1.59–3.79) 2.13 (1.10–4.11)
45–59 48/194 = 24.7% 7.39 (4.30–12.70) 6.20 (3.33–11.55) 44/151 = 29.1% 4.50 (2.92–6.93) 3.94 (2.05–7.56)
≥60 70/158 = 44.3% 13.24 (7.93–22.10) 12.30 (6.59–22.96) 39/93 = 41.9% 6.48 (4.23–9.92) 6.00 (3.10–11.58)
Marital Status P = 0.006 P = 0.35 P < 0.0001 P = 0.94
Single 14/172 = 8.1% 1 1 23/300 = 7.7% 1 1
Married (ever) 171/1009 = 16.9% 2.08 (1.24–3.50) 0.79 (0.48–1.30) 132/618 = 21.4% 2.79 (1.83–4.24) 1.03 (0.53–2.01)
BMI (kg/m2) P < 0.0001 P < 0.0001 P < 0.0001 P = 0.0004
< 25 105/892 = 11.8% 1 1 130/923 = 14.1% 1 1
25–30 48/243 = 19.7% 1.68 (1.23–2.29) 1.75 (1.28–2.40) 24/68 = 35.3% 2.51 (1.75–3.59) 2.12 (1.45–3.11)
>30 39/110 = 35.5% 3.01 (2.21–4.1) 2.72 (1.94–3.83) 7/15 = 46.7% 3.31 (1.89–5.83) 1.64 (0.84–3.22)
Occupation P = 0.99 P = 0.36 P = 0.06 P = 0.92
Unemployed 24/158 = 15.2% 1 1 20/176 = 11.4% 1 1
Manual 157/1014 = 15.5% 1.02 (0.69–1.51) 0.79 (0.53–1.18) 125/758 = 16.5% 1.45 (0.93–2.26) 1.06 (0.67–1.69)
Sedentary 11/73 = 15.1 0.99 (0.51–1.92) 1.09 (0.57–2.10) 17/73 = 23.3% 2.05 (1.14–3.68) 1.16 (0.57–2.35)
Education P < 0.0001 P = 0.61 P = 0.05 P = 0.43
No school 80/310 = 25.8% 2.05 (1.55–2.70) 1.19 (0.88–1.62) 19/94 = 20.2% 1.25 (0.80–1.95) 1.15 (0.73–1.80)
Primary 82/651 = 12.6% 1 1 86/532 = 16.2% 1 1
Secondary 23/222 = 10.4% 0.82 (0.53–1.27) 1.22 (0.77–1.94) 37/297 = 12.5% 0.77 (0.54–1.10) 1.03 (0.70–1.50)
Tertiary and beyond 7/62 = 11.3% 0.90 (0.43–1.85) 1.00 (0.44–2.28) 20/84 = 23.8% 1.47 (0.96–2.26) 1.52 (0.90–2.57)
Acres of land owned P = 0.50 P = 0.56 P = 0.58 P = 0.90
None 17/142 = 12.0% 1 1 11/96 = 11.5% 1 1
≤ 1 50/282 = 17.7% 1.48 (0.89–2.47) 1.47 (0.86–2.52) 27/157 = 17.2% 1.50 (0.78–2.88) 1.03 (0.54–1.98)
1–5 76/484 = 15.7% 1.31 (0.80–2.14) 1.30 (0.78–2.18) 64/370 = 17.3% 1.51 (0.83–2.75) 1.17 (0.65–2.09)
≥ 5 40/242 = 16.5% 1.38 (0.81–2.34) 1.24 (0.72–2.14) 51/322 = 15.8% 1.38 (0.75–2.54) 1.07 (0.59–1.93)
Tobacco use P = 0.54 P = 0.49 P = 0.22 P = 0.70
No 185/1208 = 15.3% 1 1 120/783 = 15.3% 1 1
Yes 7/37 = 18.9% 1.24 (0.63–2.44) 0.78 (0.39–1.57) 42/224 = 18.8% 1.22 (0.89–1.68) 0.94 (0.67–1.31)
Alcohol usec P = 0.70 P = 0.33 P < 0.0001 P = 0.02
None 148/986 = 15.0% 1 1 59/527 = 11.2% 1 1
0–10 34/196 = 17.4% 1.16 (0.82–1.62) 0.92 (0.66–1.28) 38/236 = 16.1% 1.44 (0.99–2.10) 1.17 (0.79–1.71)
≥10 10/62 = 16.1% 1.07 (0.60–1.93) 0.58(0.28–1.21) 64/242 = 26.5% 2.36 (1.72–3.25) 1.60 (1.13–2.26)
HIV P = 0.005 P = 0.24 P = 0.10 P = 0.02
Negative 183/1107 = 16.5% 1 1 154/923 = 16.7% 1 1
Positive 9/138 = 6.5% 0.39 (0.21–0.75) 0.69 (0.37–1.28) 8/84 = 9.5% 0.57 (0.29–1.12) 0.39 (0.17–0.87)
RPGd P < 0.0001 P = 0.02 P = 0.0002 P = 0.75
< 7 160/1101 = 14.5% 1 1 135/895 = 15.1% 1 1
7 – 11 23/126 = 18.3% 1.26 (0.84–1.87) 1.02 (0.68–1.52) 24/103 = 23.3% 1.54 (1.05–2.27) 1.17 (0.78–1.76)
≥ 11.1 8/14 = 57.1% 3.93 (2.44–6.33) 2.44 (1.32–4.51) 3/5 = 60.0% 3.98 (1.91–8.28) 1.10 (0.58–2.09)
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Table 4 Risk factors associated with hypertension using a log-link Poisson model with robust standard errors
(Continued)
Family history P = 0.11 P = 0.11 P = 0.002 P = 0.007
No 139/962 = 14.5% 1 1 114/798 = 14.3% 1 1
Yes 46/248 = 18.6% 1.28 (0.95–1.74) 1.26 (0.95–1.69) 42/180 = 23.3% 1.63 (1.19–2.24) 1.51 (1.12–2.04)
a1067 women and 839 men included in the multivariate regression model.
bEach factor is adjusted for all other factors in the table.
cDrinks of alcohol consumed per month.
dRPG – Random plasma glucose in mmol/L.
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Another population-based study from South Africa found
that HIV-infected persons had a lower prevalence of
hypertension than HIV-uninfected persons (19.5% vs
27.9%, p = 0.001) [42]. A longitudinal, prospective study in
South Africa also found decreased risk of high blood
pressure with HIV infection [43]. Yet, it has been well
established that HIV infection has adverse effects on
cardiovascular health [44]. The suggestion of an in-
verse association between HIV and hypertension should
be viewed with caution and further evaluated.
In our prior pilot campaign in Kakyerere parish in
2011, we reported a higher prevalence of hypertension
(28%), which included self-reported hypertension. In this
study we used a more rigorous definition of hyperten-
sion (using lowest of three BP measures or current use
of antihypertensives) and did not include self-reported
hypertension, which likely accounts for the difference in
prevalence estimates between the two studies. Further,
many participants reported to be hypertensive in our
pilot study in 2011 were subsequently found not to have
high BP on repeat screening at local health facilities.
This over-reporting from our pilot study urged us to de-
velop the more rigorous definition of hypertension that
was implemented in our study.
Limitations of our study included incomplete attend-
ance in the CHC, as community members who did not
attend the CHC were not screened for hypertension.
Conducting a community-wide census allowed us to
identify individuals who did not participate and account
for bias resulting from differential participation by age
in our prevalence estimate. We believe that our age-
adjusted prevalence should be a reasonable estimate of
the “true” prevalence, considering that age is the most
significant risk factor for hypertension in this commu-
nity. Measurement error in BP can lead to misclassifica-
tion of hypertensive status; however, we attempted to
minimize random error by taking three BP measure-
ments, which increases the validity of our prevalence
estimate.
The use of a multi-disease CHC to integrate services
for HIV and other NCDs could be a promising public
health approach in sub-Saharan Africa. Competition forlimited funds and health care resources between NCDs
and infectious diseases has already created a sensitive
political issue [8-10]. Our approach avoids costs related
to establishing new infrastructure and builds efficiency
by using HIV as a platform to develop services for other
chronic diseases. HIV is also the first chronic disease
that has been successfully treated with high-quality, long-
term care in resource-limited settings. Building alliances
between HIV care and NCD services will improve and ex-
pand care for NCDs, consistent with recent declarations
of the UN General Assembly [45].
Conclusions
There is a significant burden of hypertension in rural
Uganda, which is comparable to that in developed nations.
Among hypertensive patients, awareness of their condi-
tion is poor. And among those diagnosed, therapy rates
are extremely low. Prevention efforts should focus on per-
sons most likely to be hypertensive, such as overweight/
obese, alcohol consumers, and diabetics. Leveraging com-
munity-based HIV testing programs to incorporate NCD
services is an efficient use of scarce health care resources
in sub-Saharan Africa.
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